IOP Reduction in Pigmentary Glaucoma Using DSLT
NCT: NCT07281391 · RECRUITING
NCT IDNCT07281391
StatusRECRUITING
Start Date2026-03-19
Completion2027-04-01
Brief Summary
This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Frequently Asked Questions
What is IOP Reduction in Pigmentary Glaucoma Using DSLT?
IOP Reduction in Pigmentary Glaucoma Using DSLT is a clinical trial registered under NCT07281391. Current status: RECRUITING.
What is the status of NCT07281391?
The current status of NCT07281391 (IOP Reduction in Pigmentary Glaucoma Using DSLT) is: RECRUITING.
When did IOP Reduction in Pigmentary Glaucoma Using DSLT start?
IOP Reduction in Pigmentary Glaucoma Using DSLT started on 2026-03-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.